British Journal of Haematology · 1994 · 28 citations · 11 references
Life SciencesHematologyImmunologyHematopathologyImmunopathologyImmunoregulationHematologic DisordersHematologic PathologyInterferon ResponsesInterferon-based TherapyInterferon Alpha-2b TherapyProgenitor Cells
In four patients with polycythaemia vera (PV) who received interferon alpha (IFN-alpha) (3 MU subcutaneously three times a week) for 5 months, peripheral blood levels of granulocyte-macrophage colony-forming units and erythroid burst-forming units were assessed monthly. Circulating progenitors significantly decreased throughout the treatment period. Moreover, we observed an inhibitory activity of IFN-alpha on haemopoietic progenitor cells (HPC) from patients with PV in vitro. The data presented confirm previous research which has shown an inhibitory effect of IFN-alpha on HPC from patients with myeloproliferative disorders. Significant improvement in the patients' clinical and haematological conditions should encourage larger studies on IFN-alpha administration in PV patients.
11
THE GROWTH OF MOUSE BONE MARROW CELLS <i>IN VITRO</i>
TR Bradley, D Metcalf · Immunology and Cell Biology · 1966 · 1.9K citations
Norman N. Iscove, Fritz Sieber, Kaspar H. Winterhalter · Journal of Cellular Physiology · 1974 · 843 citations
Diagnosis and classification of the polycythemias.
Nathaniel I. Berlin · PubMed · 1975 · 559 citations
Medicine, Hematology, Pathology +5
Robin P Reid, V. T. DeVita, S Hellman et al. · Histopathology · 1992 · 474 citations
Medicine, Cancer Biology, Oncology +12
Clinical investigation of human alpha interferon in chronic myelogenous leukemia
Moshe Talpaz, HM Kantarjian, KB McCredie et al. · Blood · 1987 · 324 citations · Full text
Medicine, Hematology, Oncology +11